The regulation of the PI3K/AKT/FOXO1 signaling pathway has been demonstrated in different types of tumours, including colorectal cancer [26], pancreatic cancer [27], and bladder cancer [28]. This evidence concerns the gene FOXO1 and urinary bladder carcinoma.